In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Senate Democrats and White House Reach Deal to Avoid Shutdown Lawmakers are continuing to negotiate guardrails to rein in immigration agents, but the agreement was a hopeful sign that a government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results